亚低温抑制人胶质母细胞瘤细胞增殖与迁移
该体外研究探讨深度(23 °C)、中度(28 °C)和轻度(33 °C)低温对A172、U251、U87和T98G四种人胶质母细胞瘤细胞系的影响。结果显示低温以剂量依赖方式抑制细胞增殖和非定向迁移,33 °C时显著降低,28 °C时几乎完全停滞,且增殖停滞持久、定向迁移减少、细胞周期阻滞于G2/M期并改变细胞形态。结论提示中度低温可能作为胶质母细胞瘤的辅助治疗。
要点
- 低温对四种胶质母细胞瘤细胞系均抑制增殖和迁移,呈剂量依赖。
- 33 °C显著降低增殖与迁移,28 °C几乎完全停滞且增殖停滞持久。
- 28 °C改变细胞周期分布致G2/M期阻滞并损伤细胞形态。
核心结论
- 中度低温可强烈抑制胶质母细胞瘤细胞增殖和迁移,有望作为辅助治疗。
- 若体内临床前结果证实,切除边缘局部低温可能延缓肿瘤复发。
研究设计与样本
- 体外实验,使用A172、U251、U87和T98G四种人胶质母细胞瘤细胞系。
- 比较深度23 °C、中度28 °C和轻度33 °C低温对细胞增殖、迁移、形态和细胞周期的影响。
主要发现
- 四种细胞系结果一致,提示中度低温效应广泛且一致。
- 低温以剂量依赖方式抑制细胞增殖和非定向迁移,33 °C显著降低,28 °C几乎完全停滞。
- 28 °C下细胞增殖停滞持久,定向细胞迁移也减少。
- 中度低温显著改变细胞周期分布,细胞积累于G2/M期导致细胞周期阻滞。
- 28 °C低温损伤细胞膜并改变细胞形状。
关键数值与推荐
- 33 °C时细胞增殖和非定向迁移显著降低。
- 28 °C时细胞增殖和非定向迁移几乎完全停滞。
- 28 °C下定向细胞迁移减少,细胞周期阻滞于G2/M期。
临床怎么用
- 基于体外证据,中度低温可能作为胶质母细胞瘤辅助治疗手段。
- 若体内临床前结果支持,切除边缘局部低温联合现有治疗或可延缓复发。
局限性
- 仅为体外细胞系实验,尚无体内临床前或临床数据验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma is the most aggressive malignant brain tumor. Despite multimodal treatments, median survival is only 15 months for glioblastoma patients, with tumor recurring in the resection margins after surgical removal. Hypothermia is emerging as an interesting and safe treatment for several conditions. In the context of glioblastoma, we propose that moderate hypothermia could inhibit both cell proliferation and migration, and thus help prevent secondary tumor growth. METHODS: In vitro experiments on A172, U251, U87 and T98G human glioblastoma cell lines explored the effects of severe (23 °C), moderate (28 °C), and mild (33 °C) hypothermia. We further investigated the effects of moderate hypothermia on cell proliferation, migration, morphology, and cell cycle distribution. RESULTS: Similar results were obtained with all four cell lines, indicating a consistent and broad effect of moderate hypothermia. Hypothermia inhibited both cell proliferation and non-oriented migration in a dose-dependent manner, with a significant reduction at 33 °C and almost total arrest at 28 °C. Cell proliferation arrest was long-lasting and oriented cell migration was also reduced at 28 °C. Moreover, moderate hypothermia significantly altered cell cycle distribution, with cells accumulating in the G2/M phase, leading to cell cycle arrest. Lastly, hypothermia at 28 °C also affected cell morphology by deteriorating cell membranes and altering cell shape. CONCLUSIONS: The presented results demonstrate that moderate hypothermia could be a promising adjuvant therapy for glioblastoma treatment as it strongly inhibits both cell proliferation and migration. If in vivo preclinical results corroborate our findings, therapeutic hypothermia applied at the resection margins could probably delay tumor recurrence, combined with current treatments.
引用
- Fulbert C, Gaude C, Sulpice E, et al. Moderate hypothermia inhibits both proliferation and migration of human glioblastoma cells. J Neurooncol. 2019. PMID: 31482266. doi:10.1007/s11060-019-03263-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。